Kelly Dooley and Gavin Churchyard on TB prevention in people with HIV

from The Lancet HIV in conversation with · host The Lancet HIV

Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published Jun 3, 2020

Embed this episode

Attribution link and audio player

Ready to play

Kelly Dooley and Gavin Churchyard on TB prevention in people with HIV

0:00 15:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet HIV in conversation with?

This episode is 15 minutes long.

When was this The Lancet HIV in conversation with episode published?

This episode was published on June 3, 2020.

Can I download this The Lancet HIV in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!